Evidence map›Paper›PMID 30015453›Full record

ReviewPolish journal of microbiology2018

Brucella - Virulence Factors, Pathogenesis and Treatment.

Patrycja Głowacka, Dorota Żakowska, Katarzyna Naylor, Marcin Niemcewicz, Agata Bielawska-Drózd

Open access · goldAbstract readReview
In one paragraph

Review in Polish journal of microbiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 125 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
125citing papers in PubMed, 3 pooled it
9.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

125 citing papers in PubMed, 3 syntheses or guidelines pooled it, 201 citations in OpenAlex.

  1. Research hotspots and development trends ofFrontiers in microbiology · 2025
    Pooled it
  2. Efficacy ofTransboundary and emerging diseases · 2024
    Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Journal of medical microbiology · 2026
    Article
  7. Article
  8. Article
  9. Review
  10. ComparativeVeterinary world · 2026
    Article
  11. Article
  12. Sequencing the whole genome of aMicrobiology resource announcements · 2026
    Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Frontiers in immunology · 2026
    Article

65 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Patrycja GłowackaBiological Threats Identification and Countermeasure Center of the General Karol Kaczkowski Military Institute of Hygiene and Epidemiology,Puławy,Poland.
Dorota ŻakowskaBiological Threats Identification and Countermeasure Center of the General Karol Kaczkowski Military Institute of Hygiene and Epidemiology,Puławy,Poland.
Katarzyna NaylorLublin Medical University, Department of Didactics and Medical Simulation,Lublin,Poland.
Marcin NiemcewiczBiological Threats Identification and Countermeasure Center of the General Karol Kaczkowski Military Institute of Hygiene and Epidemiology,Puławy,Poland.
Agata Bielawska-DrózdBiological Threats Identification and Countermeasure Center of the General Karol Kaczkowski Military Institute of Hygiene and Epidemiology,Puławy,Poland.
Wojskowy Instytut Higieny i Epidemiologii · PLMedical University of Lublin · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Brucellae are Gram-negative, small rods infecting mammals and capable of causing disease called brucellosis. The infection results in abortion and sterility in domestic animals (sheeps, pigs, rams etc). Especially dangerous for humans are: Brucella melitensis, Brucella suis, Brucella abortus, and Brucella canis that trigger unspecific symptoms (flu-like manifestation). Brucella rods are introduced via host cells, by inhalation, skin abrasions, ingestion or mucosal membranes. The most important feature of Brucella is the ability to survive and multiply within both phagocytic and non-phagocytic cells. Brucella does not produce classical virulence factors: exotoxin, cytolisins, exoenzymes, plasmids, fimbria, and drug resistant forms. Major virulence factors are: lipopolysaccharide (LPS), T4SS secretion system and BvrR/BvrS system, which allow interaction with host cell surface, formation of an early, late BCV (Brucella Containing Vacuole) and interaction with endoplasmic reticulum (ER) when the bacteria multiply. The treatment of brucellosis is based on two-drug therapy, the most common combinations of antibiotics are: doxycycline with rifampicin or fluoroquinolones with rifampicin. Currently, also other methods are used to disrupt Brucella intracellular replication (tauroursodeoxycholic acid or ginseng saponin fraction A).

Indexed as

Host-Pathogen InteractionsVirulence FactorsAnimalsAnti-Bacterial AgentsBrucellaBrucellosisEndoplasmic ReticulumHumansLipopolysaccharidesMacrophagesSheepSwineType IV Secretion SystemsAnti-Bacterial AgentsLipopolysaccharidesType IV Secretion SystemsVirulence FactorsBrucellaendoplasmic reticulummacrophagereplicationvirulence factors

Identifiers

PMID30015453
PMCPMC7256693
OpenAlexW2843026457

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.